Search results for "Diabetes"
Overweight, obesity poorly managed in type 1 diabetes
While U.S. adults with type 1 diabetes have rates of overweight and obesity virtually identical to those in the general adult population, only about 50% received lifestyle recommendations for weight management from clinicians or tried lifestyle modifications.
https://acpinternist.org/weekly/archives/2023/02/14/4.htm
14 Feb 2023
Take TIAs as seriously as a stroke
Internal medicine physicians play a critical role in educating patients about the seriousness of transient ischemic attacks and preventing their recurrence.
https://acpinternist.org/archives/2023/05/take-tias-as-seriously-as-a-stroke.htm
1 May 2023
Subscribe
ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
https://acpinternist.org/subscribe/
Nocturnal hypoglycemia underdiagnosed in older patients on insulin for type 2 diabetes
An industry-funded study of patients ages 75 years and older who were taking insulin for type 2 diabetes found that almost two-thirds (65.2%) experienced nocturnal hypoglycemia during a 28-day study period.
https://acpinternist.org/weekly/archives/2023/04/04/1.htm
4 Apr 2023
Closing the gap on osteoporosis
A new clinical guideline from ACP focuses on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
https://acpinternist.org/archives/2023/05/closing-the-gap-on-osteoporosis.htm
1 May 2023
KDIGO guideline summary provides key points for treating diabetes, chronic kidney disease
Authors from the Kidney Disease: Improving Global Outcomes (KDIGO) Work Group provided a synopsis of key recommendations on comprehensive care, glycemic monitoring and targets, lifestyle interventions, antihyperglycemic therapies, and educational and integrated care approaches.
https://acpinternist.org/weekly/archives/2023/01/10/1.htm
10 Jan 2023
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://acpinternist.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
Experts offer optimism on overcoming obesity
ACP and Annals of Internal Medicine hosted a forum on managing the epidemic levels of obesity in America.
https://acpinternist.org/archives/2023/05/experts-offer-optimism-on-overcoming-obesity.htm
1 May 2023
Nonsugar sweeteners should not be used for weight loss, WHO guideline states
The World Health Organization (WHO) cited a lack of evidence suggesting that short-term use of nonsugar sweeteners affected body weight or other measures of adiposity, as well as possible long-term undesirable effects on noncommunicable diseases and death.
https://acpinternist.org/weekly/archives/2023/05/23/2.htm
23 May 2023
Big barrier to buprenorphine removed
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
https://acpinternist.org/archives/2023/03/big-barrier-to-buprenorphine-removed.htm
1 Mar 2023